Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Non-Current Assets (2019 - 2023)

Historic Other Non-Current Assets for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $1.0 million.

  • ADC Therapeutics' Other Non-Current Assets rose 1379.31% to $1.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.0 million, marking a year-over-year increase of 1379.31%. This contributed to the annual value of $902000.0 for FY2022, which is 13005873.02% up from last year.
  • Per ADC Therapeutics' latest filing, its Other Non-Current Assets stood at $1.0 million for Q3 2023, which was up 1379.31% from $1.4 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Other Non-Current Assets high stood at $1.4 million for Q2 2023, and its period low was $368.0 during Q4 2019.
  • Its 5-year average for Other Non-Current Assets is $635702.4, with a median of $795000.0 in 2021.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 17753496.14% in 2021, then skyrocketed by 1379.31% in 2023.
  • Quarter analysis of 5 years shows ADC Therapeutics' Other Non-Current Assets stood at $368.0 in 2019, then grew by 5.71% to $389.0 in 2020, then skyrocketed by 78.15% to $693.0 in 2021, then soared by 130058.73% to $902000.0 in 2022, then grew by 13.41% to $1.0 million in 2023.
  • Its Other Non-Current Assets stands at $1.0 million for Q3 2023, versus $1.4 million for Q2 2023 and $1.2 million for Q1 2023.